Transition report pursuant to Rule 13a-10 or 15d-10

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Dec. 31, 2022
May 26, 2023
Document and Entity Information    
Document Type 10-QT  
Document Quarterly Report false  
Document Transition Report true  
Document Period Start Date Oct. 01, 2022  
Document Period End Date Dec. 31, 2022  
Entity File Number 001-35963  
Entity Registrant Name NEUBASE THERAPEUTICS, INC.  
Entity Incorporation, State Code DE  
Entity Tax Identification Number 46-5622433  
Entity Address, Address Line One 350 Technology Drive  
Entity Address, City or Town Pittsburgh  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 15219  
City Area Code 412  
Local Phone Number 763-3350  
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Trading Symbol NBSE  
Security Exchange Name NASDAQ  
Entity's Reporting Status Current Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   33,810,356
Entity Central Index Key 0001173281  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Amendment Flag false